This study aims to analyze trends in HIV incidence, HIV prevalence, and HIV risk behaviors in a longitudinal study of street-recruited injection drug users (IDUs) spanning 12 years in San Francisco. Interventions implemented in San Francisco during that time to prevent transmission of HIV among IDUs have included HIV testing and counseling (by the applicant and others), drug treatment, community health outreach with """"""""bleach and teach"""""""" protocols, and syringe exchange programs. In the proposed study, data collected prospectively from 1986 through 1997 will be analyzed to assess the impact of HIV prevention interventions implemented during this period, and to better understand the changing epidemiology of HIV infection in the wake of these interventions. Although funding for this study was provided initially by NIDA (grant # R01-DA04212, 1986-1989), for the past 8 years, data have been collected with funds provided by the local health department for the purpose of HIV prevention, not research. As a consequence, resources have not been provided for data analysis since 1989, and the extensive opportunities for epidemiologic and prevention research have not been fully exploited. The proposed study will therefore accomplish substantial research objectives without the need for additional data collection and with a relatively small expenditure of funds.
The specific aims of this study are: 1) to determine trends in HIV incidence and factors associated with HIV seroconversion among street-recruited IDUs in San Francisco, 1986 to 1997; 2) to determine trends in HIV prevalence from 1986 to 1997 and trends in factors associated with HIV prevalence among street-recruited injection drug users, and to analyze possible reasons for the observed decline in seroprevalence from 1995 through 1997; 3) to determine trends in HIV risk behaviors and factors associated with changes in injection-related and sex-related risk behaviors among street-recruited IDUs, 1986 to 1997. Factors to be examined for their association with HIV incidence, HIV prevalence, and HIV risk behaviors will include sociodemographic characteristics, risk behaviors, and exposure to HIV prevention interventions.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA012109-02
Application #
2898294
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Cooper, Leslie
Project Start
1998-08-01
Project End
2001-07-31
Budget Start
1999-08-01
Budget End
2000-07-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
O'Brien, Thomas R; Pfeiffer, Ruth M; Paquin, Ashley et al. (2015) Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance. J Hepatol 63:1103-10
Prokunina-Olsson, Ludmila; Muchmore, Brian; Tang, Wei et al. (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45:164-71
Uccellini, Lorenzo; Tseng, Fan-Chen; Monaco, Alessandro et al. (2012) HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations. Hepatology 56:86-94
Dias, Paulo Telles; Hahn, Judith A; Delwart, Eric et al. (2011) Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California. BMC Infect Dis 11:208
Shebl, Fatma M; Pfeiffer, Ruth M; Buckett, Dianna et al. (2011) IL28B rs12979860 genotype and spontaneous clearance of hepatitis C virus in a multi-ethnic cohort of injection drug users: evidence for a supra-additive association. J Infect Dis 204:1843-7
Edlin, Brian R; Shu, Marla A; Winkelstein, Emily et al. (2009) More rare birds, and the occasional swan. Gastroenterology 136:2412-4
Tseng, F-C; Edlin, B R; Zhang, M et al. (2008) The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use. J Viral Hepat 15:690-8
Bacchetti, Peter; Tien, Phyllis C; Seaberg, Eric C et al. (2007) Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression. BMC Infect Dis 7:145
Kral, Alex H; Page-Shafer, Kimberly; Edlin, Brian R et al. (2004) Persistent HIV incidence among injection drug users in San Francisco during the 1990s: results of five studies. J Acquir Immune Defic Syndr 37:1667-9
Edlin, Brian R (2002) Prevention and treatment of hepatitis C in injection drug users. Hepatology 36:S210-9

Showing the most recent 10 out of 14 publications